**Core Concept**
Pentostatin is a chemotherapeutic agent used in the treatment of hairy cell leukemia, acting through a specific mechanism of action to inhibit the growth of cancer cells. This involves the interference with the purine metabolism pathway, which is crucial for the synthesis of nucleic acids.

**Why the Correct Answer is Right**
Pentostatin specifically inhibits the enzyme adenosine deaminase (ADA), which is responsible for the breakdown of deoxyadenosine and deoxyguanosine. By blocking ADA, pentostatin leads to the accumulation of these toxic metabolites, ultimately causing cell death in hairy cell leukemia cells. This mechanism of action is critical for its therapeutic effects in this disease.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because pentostatin does not act through the inhibition of thymidylate synthase, which is a target for other chemotherapeutic agents like 5-fluorouracil.

**Option B:** This option is incorrect because pentostatin does not inhibit the enzyme dihydrofolate reductase (DHFR), which is targeted by drugs like methotrexate.

**Option C:** This option is incorrect because pentostatin does not act through the inhibition of DNA topoisomerase II, which is the target of drugs like etoposide.

**Clinical Pearl / High-Yield Fact**
Pentostatin's mechanism of action through the inhibition of adenosine deaminase highlights the importance of purine metabolism in cancer cell growth and survival. This knowledge can be applied to other chemotherapeutic agents that target similar pathways.

**Correct Answer: D. Adenosine Deaminase**